Under construction – not a live service
Sign in
Taking people in TaiwanNo phase

Testing lower beta-blocker doses in people with atrial fibrillation

Tests a lower dose of beta-blocker in adults with atrial fibrillation, a heart rhythm disorder.

Plain-language title generated from the registry record
Registry title: The Effect of Beta-blocker on Chronotropic Response and Cardiorespiratory Fitness in Patients With Atrial Fibrillation

Key facts

Where
Taipei, TaiwanSee the site

Where in Taiwan

  • National Taiwan University HospitalTaipei, TaiwanTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
National Taiwan University Hospital
Trial code
NCT05332457
Record updated
24 March 2025
Original description
This is a prospective study to evaluate changes in exercise capacity and chronotropic response to exercise before and after beta-blocker dosage reduction in patients with atrial fibrillation (AF).Read full original descriptionShow less

The Effect of Beta-blocker on Chronotropic Response and Cardiorespiratory Fitness in Patients With Atrial Fibrillation: a Crossover Randomized Controlled Trial.

This is a prospective study to evaluate changes in exercise capacity and chronotropic response to exercise before and after beta-blocker dosage reduction in patients with atrial fibrillation (AF).

Inclusion: > 20 years of age; Clinically stable patients with persistent atrial fibrillation using beta-blocker as rate-control agent without dosage adjustment for at least 3 months; Resting heart rate < 80 bpm; Left ventricular ejection fraction > 50%.

Exclusion: Beta-blocker usage due to indications other than rate control for atrial fibrillation; Inability to perform a cardiopulmonary exercise testing; Presence of contraindications for cardiopulmonary exercise testing according to the American College of Sports Medicine's Guidelines for Exercise Testing and Prescription; Patients with implantable cardioverter defibrillator or pacemaker; Pregnancy; Inability to provide informed consent.

ClinicalTrials.gov NCT05332457